The HepG2 cells were treated with ActD for 6 h, and the p53 expression level was examined
by immunofluorescence imaging.
Figure 4: Actinomycin D (ActD)- induced p53 expression as revealed
by immunofluorescence imaging.
Figure 5: Effects of kinase inhibitors on p53 expression as revealed
by immunofluorescence imaging.